Catherine E. Gleason

1.9k total citations
23 papers, 1.5k citations indexed

About

Catherine E. Gleason is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Catherine E. Gleason has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Catherine E. Gleason's work include Pancreatic function and diabetes (9 papers), Metabolism, Diabetes, and Cancer (6 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Catherine E. Gleason is often cited by papers focused on Pancreatic function and diabetes (9 papers), Metabolism, Diabetes, and Cancer (6 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Catherine E. Gleason collaborates with scholars based in United States, Australia and Denmark. Catherine E. Gleason's co-authors include R. Paul Robertson, Jamie S. Harmon, Phuong Oanh T. Tran, Yasuhito Tanaka, Morris J. Birnbaum, Vincent Poitout, Christopher B. Newgard, Lee A. Witters, Danhong Lu and Robert Gourlay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Catherine E. Gleason

22 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine E. Gleason United States 16 716 647 443 288 260 23 1.5k
Elaine Xu Canada 17 762 1.1× 565 0.9× 536 1.2× 177 0.6× 372 1.4× 22 1.7k
Wissal El-Assaad Canada 15 985 1.4× 856 1.3× 555 1.3× 274 1.0× 371 1.4× 17 1.9k
Alpana Bhattacharjee Canada 19 607 0.8× 634 1.0× 309 0.7× 200 0.7× 287 1.1× 24 1.4k
Roberto A. Calle United States 26 1.3k 1.8× 694 1.1× 795 1.8× 267 0.9× 448 1.7× 72 2.3k
M. Anello Italy 17 819 1.1× 1.2k 1.8× 668 1.5× 391 1.4× 445 1.7× 23 1.7k
Isabelle Briaud United States 16 776 1.1× 1.0k 1.6× 455 1.0× 350 1.2× 313 1.2× 22 1.5k
Guanlan Xu United States 17 669 0.9× 603 0.9× 308 0.7× 339 1.2× 177 0.7× 27 1.3k
Bernadette Neve France 17 1.3k 1.8× 740 1.1× 316 0.7× 255 0.9× 305 1.2× 30 2.0k
Sarah Hummasti United States 8 564 0.8× 577 0.9× 200 0.5× 180 0.6× 309 1.2× 8 1.3k
Meriem Semache Canada 14 582 0.8× 587 0.9× 374 0.8× 218 0.8× 369 1.4× 21 1.2k

Countries citing papers authored by Catherine E. Gleason

Since Specialization
Citations

This map shows the geographic impact of Catherine E. Gleason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine E. Gleason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine E. Gleason more than expected).

Fields of papers citing papers by Catherine E. Gleason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine E. Gleason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine E. Gleason. The network helps show where Catherine E. Gleason may publish in the future.

Co-authorship network of co-authors of Catherine E. Gleason

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine E. Gleason. A scholar is included among the top collaborators of Catherine E. Gleason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine E. Gleason. Catherine E. Gleason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Zanlin, Feng Wang, Bidisha Saha, et al.. (2022). Interactions between mTORC2 core subunits Rictor and mSin1 dictate selective and context-dependent phosphorylation of substrate kinases SGK1 and Akt. Journal of Biological Chemistry. 298(9). 102288–102288. 23 indexed citations
2.
Saha, Bidisha, et al.. (2022). WNK1 is a chloride-stimulated scaffold that regulates mTORC2 activity and ion transport. Journal of Cell Science. 135(23). 16 indexed citations
3.
Paulo, Esther, Ambre M. Bertholet, Seung‐Hwan Lee, et al.. (2021). Role of mTORC2 in biphasic regulation of brown fat metabolism in response to mild and severe cold. Journal of Biological Chemistry. 296. 100632–100632. 13 indexed citations
4.
Sørensen, Mads Vaarby, Bidisha Saha, Peng Wu, et al.. (2019). Potassium acts through mTOR to regulate its own secretion. JCI Insight. 4(11). 55 indexed citations
5.
Gleason, Catherine E., Juan A. Osés-Prieto, Kathy H. Li, et al.. (2019). Phosphorylation at distinct subcellular locations underlies specificity in mTORC2-mediated activation of SGK1 and Akt. Journal of Cell Science. 132(7). 47 indexed citations
6.
Morze, Cornelius von, Irene Marco‐Rius, Eugene Milshteyn, et al.. (2018). Non-invasive detection of divergent metabolic signals in insulin deficiency vs. insulin resistance in vivo. Scientific Reports. 8(1). 2088–2088. 17 indexed citations
7.
Gleason, Catherine E., Gustavo Frindt, Michael Ng, et al.. (2014). mTORC2 regulates renal tubule sodium uptake by promoting ENaC activity. Journal of Clinical Investigation. 125(1). 117–128. 61 indexed citations
8.
Gleason, Catherine E., Alban Ordureau, Robert Gourlay, J. Simon C. Arthur, & Philip Cohen. (2011). Polyubiquitin Binding to Optineurin Is Required for Optimal Activation of TANK-binding Kinase 1 and Production of Interferon β. Journal of Biological Chemistry. 286(41). 35663–35674. 133 indexed citations
9.
Gleason, Catherine E., Yun Ning, Tara P. Cominski, et al.. (2009). Role of Insulin-Like Growth Factor-Binding Protein 5 (IGFBP5) in Organismal and Pancreatic β-Cell Growth. Endocrine Reviews. 30(7). 930–930. 1 indexed citations
10.
Gleason, Catherine E., Yun Ning, Tara P. Cominski, et al.. (2009). Role of Insulin-Like Growth Factor-Binding Protein 5 (IGFBP5) in Organismal and Pancreatic β-Cell Growth. Molecular Endocrinology. 24(1). 178–192. 33 indexed citations
11.
Gleason, Catherine E., Danhong Lu, Lee A. Witters, Christopher B. Newgard, & Morris J. Birnbaum. (2007). The Role of AMPK and mTOR in Nutrient Sensing in Pancreatic β-Cells. Journal of Biological Chemistry. 282(14). 10341–10351. 156 indexed citations
12.
Tran, Phuong Oanh T., Catherine E. Gleason, & R. Paul Robertson. (2002). Inhibition of Interleukin-1β-Induced COX-2 and EP3 Gene Expression by Sodium Salicylate Enhances Pancreatic Islet β-Cell Function. Diabetes. 51(6). 1772–1778. 96 indexed citations
13.
Harmon, Jamie S., Catherine E. Gleason, Yasuhito Tanaka, Vincent Poitout, & R. Paul Robertson. (2001). Antecedent Hyperglycemia, Not Hyperlipidemia, Is Associated With Increased Islet Triacylglycerol Content and Decreased Insulin Gene mRNA Level in Zucker Diabetic Fatty Rats. Diabetes. 50(11). 2481–2486. 116 indexed citations
14.
Gleason, Catherine E., Michael Gonzalez, Jamie S. Harmon, & R. Paul Robertson. (2000). Determinants of glucose toxicity and its reversibility in the pancreatic islet β-cell line, HIT-T15. American Journal of Physiology-Endocrinology and Metabolism. 279(5). E997–E1002. 70 indexed citations
15.
Tran, Phuong Oanh T., Catherine E. Gleason, Vincent Poitout, & R. Paul Robertson. (1999). Prostaglandin E2 Mediates Inhibition of Insulin Secretion by Interleukin-1β. Journal of Biological Chemistry. 274(44). 31245–31248. 87 indexed citations
16.
Harmon, Jamie S., et al.. (1999). In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression.. Diabetes. 48(10). 1995–2000. 87 indexed citations
17.
Tanaka, Yasuhito, Catherine E. Gleason, Phuong Oanh T. Tran, Jamie S. Harmon, & R. Paul Robertson. (1999). Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proceedings of the National Academy of Sciences. 96(19). 10857–10862. 385 indexed citations
18.
Tanaka, Yoshito, Catherine E. Gleason, Elizabeth Oseid, et al.. (1996). Prevention of glucose toxicity in HIT-T15 cells and ZDF rats by an antioxidant, N-acetyl-L-cysteine. Investigative Ophthalmology & Visual Science. 37(3).
19.
Browder, William, et al.. (1985). Adverse effect of splenectomy in experimental peritonitis. Journal of Surgical Research. 38(6). 574–581. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elaine Xu Breakdown of academic impact, for papers by Wissal El-Assaad Breakdown of academic impact, for papers by Alpana Bhattacharjee Breakdown of academic impact, for papers by Roberto A. Calle Breakdown of academic impact, for papers by M. Anello Breakdown of academic impact, for papers by Isabelle Briaud Breakdown of academic impact, for papers by Guanlan Xu Breakdown of academic impact, for papers by Bernadette Neve Breakdown of academic impact, for papers by Sarah Hummasti Breakdown of academic impact, for papers by Meriem Semache
Rankless by CCL
2026